UpdatesPlus - Immunology

Description

Source URL:

https://investors.artivabio.com/News-and-Events/news/news-details/2026/Artiva-Announces-Positive-Initial-Clinical-Data-with-AlloNK-Across-Multiple-Autoimmune-Diseases-and-FDA-Alignment-to-Initiate-Phase-3-Registrational-Trial-in-Rheumatoid-Arthritis-in-2026/default.aspx